Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OAD Treatment”

38 trials

Showing 20 of 38 results

Post-approval studies (Phase 4)Study completedNCT00941148
What this trial is testing

Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin

Who this might be right for
Type 2 Diabetic PatientsInsufficient Metabolic ControlOAD Treatment
ikfe-CRO GmbH 30
Large-scale testing (Phase 3)Study completedNCT02207374
What this trial is testing

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 601
Early research (Phase 1)Study completedNCT02176005
What this trial is testing

Safety and Efficacy Study of DAV132 in Healthy Volunteers

Who this might be right for
Healthy
Da Volterra 44
Large-scale testing (Phase 3)Study completedNCT02086929
What this trial is testing

Trazodone Once a Day in Major Depression Disorder

Who this might be right for
Major Depressive Disorder
Aziende Chimiche Riunite Angelini Francesco S.p.A 364
Large-scale testing (Phase 3)Study completedNCT01513590
What this trial is testing

A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 394
Large-scale testing (Phase 3)Study completedNCT01512108
What this trial is testing

Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 363
Post-approval studies (Phase 4)Study completedNCT02606357
What this trial is testing

Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 242
Large-scale testing (Phase 3)Ended earlyNCT00562692
What this trial is testing

Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease

Who this might be right for
Heart Failure
The Alfred 6
Large-scale testing (Phase 3)Study completedNCT00598793
What this trial is testing

Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 242
Post-approval studies (Phase 4)Study completedNCT02954692
What this trial is testing

Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 112
Large-scale testing (Phase 3)Study completedNCT00184600
What this trial is testing

Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 708
Not applicableLooking for participantsNCT06838286
What this trial is testing

Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical 10,000
Large-scale testing (Phase 3)Study completedNCT01006291
What this trial is testing

Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 687
Large-scale testing (Phase 3)Study completedNCT00982644
What this trial is testing

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,030
Testing effectiveness (Phase 2)Study completedNCT06202079
What this trial is testing

A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Gan and Lee Pharmaceuticals, USA 179
Large-scale testing (Phase 3)Study completedNCT06881264
What this trial is testing

A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes

Who this might be right for
Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs
Jiangsu HengRui Medicine Co., Ltd. 401
Not applicableStudy completedNCT03748810
What this trial is testing

Head-to-head Comparison of Empagliflozin and Dapagliflozin

Who this might be right for
Type2 Diabetes
Chungbuk National University Hospital 600
Testing effectiveness (Phase 2)Study completedNCT00611884
What this trial is testing

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 245
Not applicableStudy completedNCT00842192
What this trial is testing

An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,155
Post-approval studies (Phase 4)Study completedNCT00521690
What this trial is testing

The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 25
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation